OBJECTIVES Different probiotic strains used in clinical trials have shown prophylactic properties in different inflammatory diseases of the gastrointestinal tract. This study was aimed to investigate the influence of Escherichia coli strain Nissle 1917 (EcN) components on the integrity of the Caco-2 cell monolayer (human adenocarcinoma cell line).
More than a marine propeller – the flagellum of the probiotic Escherichia coli strain Nissle 1917 is the major adhesin mediating binding to human mucus. International Journal of Medical Microbiology.
Probiotics may be an effective solution for the management of gut microbiomes, but there is a lack of studies regarding the physiology of probiotics in microgravity. Here, we investigated the effects of microgravity on the probiotic Escherichia coli Nissle 1917 (EcN) by comparing transcriptomic data during exponential and stationary growth
INTRODUCTION. Escherichia coli Nissle was one of the first strains used as a probiotic (reviewed in reference 1).It was isolated in 1917 from a German soldier who remained healthy while his comrades succumbed to infections caused by Shigella.
We engineered these cortisol responsive genetic elements from C. scindens into an enteric probiotic, E. coli Nissle 1917, to drive the expression of a fluorescent reporter allowing for the designing, testing, and building of a robust and physiologically relevant novel cortisol probiotic sensor. This smart probiotic was further engineered to be
One such example is the probiotic bacterium Escherichia coli Nissle 1917 (E. coli Nissle, or EcN), a strain that was first isolated in WWI from the stool of a soldier who did not develop
Clinical effectiveness and dose dependency of E. coli Nissle (EcN) enemas were investigated in ulcerative colitis (UC). Methods: In a double-blind study, 90 patients with moderate distal activity in UC were randomly assigned to treatment with either 40, 20, or 10 ml enemas (N = 24, 23, 23) containing 10E8 EcN/ml or placebo (N = 20). Aims To assess protective efficacy of genetically modified Escherichia coli Nissle 1917 (EcN) on metabolic effects induced by chronic consumption of dietary fructose. Materials and Methods EcN was genetically modified with fructose dehydrogenase (fdh) gene for conversion of fructose to 5-keto-D-fructose and mannitol-2-dehydrogenase (mtlK) gene for conversion to mannitol, a prebiotic. Charles Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 1617–1623 (2004). Article Google Scholar DZcTAII.
  • orcayu10v6.pages.dev/964
  • orcayu10v6.pages.dev/726
  • orcayu10v6.pages.dev/496
  • orcayu10v6.pages.dev/887
  • orcayu10v6.pages.dev/327
  • orcayu10v6.pages.dev/421
  • orcayu10v6.pages.dev/879
  • orcayu10v6.pages.dev/295
  • orcayu10v6.pages.dev/199
  • orcayu10v6.pages.dev/158
  • orcayu10v6.pages.dev/68
  • orcayu10v6.pages.dev/48
  • orcayu10v6.pages.dev/759
  • orcayu10v6.pages.dev/172
  • orcayu10v6.pages.dev/473
  • escherichia coli nissle 1917 probiotic